New drug tested for Hard-to-Treat bowel disease
NCT ID NCT06693908
Summary
This early-stage study is testing an investigational drug called vixarelimab in people with moderate to severe ulcerative colitis (UC) who haven't responded well to other treatments. The main goal is to see how the drug affects the gut and to check its safety. Researchers will enroll about 24 participants to measure drug levels and changes in colon tissue.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Charité Research Organisation GmbH
RECRUITINGBerlin, 10117, Germany
Conditions
Explore the condition pages connected to this study.